Trial Profile
Prospective Observational Study to Assess Personality Disorders in Prison Populations for Hepatitis C Treatment.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Aug 2013
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C; Personality disorders
- Focus Therapeutic Use
- Acronyms Perseo
- 28 Aug 2013 New trial record